Full-Time

Vice President of Clinical Research Development

Mangrove Management Partners

Mangrove Management Partners

11-50 employees

Invests in vascular surgery quality improvements

Compensation Overview

$140k - $200k/yr

Burlington, MA, USA

In Person

Must commute to Burlington, MA office at least once per week.

Category
Biology & Biotech (1)

Get referred to Mangrove Management Partners

See people who can refer or advise you

Requirements
  • Ten or more years of experience in business leadership, including at least five years in leadership roles within a contract research organization, a site management organization, or sponsor-side research operations.
  • Deep understanding of device trial operations, ideally with experience in vascular, endovascular, interventional radiology, or related device areas.
  • Experience managing clinical partnerships across outpatient centers, hospitals, and integrated health systems.
  • Entrepreneurial mindset and ability to thrive in a growth-stage organization.
  • Exceptional relationship management, communication, and operational strategy skills.
Responsibilities
  • Design and execute a comprehensive strategy to evolve the current outpatient-based research program into a full-scale SMO/CRO.
  • Define organizational structure, processes, and governance to support scalable, compliant, and efficient multi-site operations.
  • Build partnerships with hospital systems, physician groups, device manufacturers, and early-stage device companies to broaden the trial portfolio.
  • Lead site identification, activation, contracting, budgeting, and strategic planning across hospital systems, outpatient centers, and external investigator sites.
  • Mature the existing functional architecture (clinical operations, regulatory, data, monitoring, site management, quality assurance, vendor management, etc.).
  • Advance centralized operations for data management, monitoring, and regulatory oversight.
  • Identify and onboard additional research sites and investigators beyond Vascular Breakthroughs’ current footprint.
  • Develop relationships with sponsors and contract research organizations seeking high-quality, device-focused research sites.
  • Build the commercial model, pricing structure, and growth strategy for the new SMO/CRO business unit.
  • Represent Vascular Breakthroughs’ research capabilities at conferences, advisory boards, and industry partnership forums.
  • Lead efforts to diversify research beyond vascular interventions into adjacent procedural or surgical device categories.
  • Maintain focus on device trials while leveraging existing operational efficiency and physician expertise in outpatient procedural care.
  • Recruit, mentor, and develop clinical research and operations teams.
  • Foster a culture of scientific integrity, regulatory compliance, and operational excellence.
Mangrove Management Partners

Mangrove Management Partners

View

Mangrove Management Partners partners with vascular surgeons and interventionalists to improve patient outcomes while lowering costs in the healthcare system. The company focuses on vascular surgery and interventional procedures, offering best-in-class capabilities for healthcare management to support clinicians, payers, and patients. Its offering centers on investing in quality improvements and growth within the healthcare sector, aligning the interests of patients, providers, and investors to create a more efficient system. The revenue model comes from strategic investments in quality initiatives and sector growth, leveraging leadership expertise across healthcare, investment management, technology, and business development. By combining clinical partnerships with targeted investments and operational improvements, Mangrove aims to enhance outcomes, reduce costs, and drive sustainable growth in healthcare.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

Lexington, Kentucky

Founded

2019

Get referred to Mangrove Management Partners

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • January 8, 2026 launched TVCG CARES International for complex vascular anomalies.
  • April 22, 2026 outreach events expanded patient awareness across Massachusetts.
  • July 24, 2026 hiring pages and leadership listings signal active scaling and operating continuity.

What critics are saying

  • A 2021 Series B implies dependence on follow-on capital before 2027 expansion.
  • Surgery Partners’ 2026 acquisition of Preferred Vascular Group intensifies outpatient vascular competition.
  • If reimbursement compresses, Mangrove’s physician-affiliation model loses margin and strategic relevance quickly.

What makes Mangrove Management Partners unique

  • Mangrove pairs physician management with The Vascular Care Group’s specialty vascular network.
  • Its July 24, 2026 website emphasizes outcomes, lower costs, and research-enabled standardization.
  • Mark Rowe’s expanded clinical-operations role ties leadership directly to care delivery execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Paid Holidays

Flexible Work Hours

Remote Work Options

Hybrid Work Options

401(k) Retirement Plan

Wellness Program

Mental Health Support

Phone/Internet Stipend

Home Office Stipend

Professional Development Budget

Conference Attendance Budget

Family Planning Benefits

Fertility Treatment Support

Stock Options

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

-2%
Business Wire
Jan 25th, 2024
Dr. Paul Gagne Assumes Expanded Role As Chief Of Clinical Operations And Research At Mangrove Management Partners

DARIEN, Conn. BURLINGTON, Mass.--(BUSINESS WIRE)--The Vascular Care Group (“TVCG”) and Mangrove Management Partners (“Mangrove”, the affiliated management company of TVCG), announced today that Dr. Paul Gagne, will assume an expanded leadership role as Chief of Clinical Operations and Research. In this capacity, Dr. Paul Gagne will further lead and enhance clinical operations and research initiatives, with a strong focus on improving standardization of care and clinical outcomes. Dr

Business Wire
Oct 20th, 2021
Mangrove Management Partners Closes Series B Equity Financing Round

LEXINGTON, Mass.--(BUSINESS WIRE)--Mangrove Management Partner, a company focused on the delivery of vascular care, today announced it has closed a Series B equity financing round.